Cell-specific viral gene therapy of a Hurthle cell tumor

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1407-1414

  Zhang, Rusheng ^a   Straus, Francis H ^a   Degroot, Leslie J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS TRANSDUCING THYMIDINE KINASE; AMINOTRANSFERASE; GANCICLOVIR; LUCIFERASE; THYMIDINE KINASE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ADENOVIRUS; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ONCOCYTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; THYROID CANCER; VIRAL GENE THERAPY; VIRUS GENE;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 0036959867     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8276     Document Type: Article

References (55)

1. Pacini F, DeGroot LJ 1998 Thyroid carcinoma. In: Grossman A, ed. Clinical endocrinology. 2nd ed. Oxford: Blackwell Science Ltd.; 359-371
2. DeGroot LJ 1995 Thyroid neoplasm. In: DeGroot LJ, ed. Endocrinology. 3rd ed. Philadelphia: W. B. Saunders Company; 834-854
3. Lowe DG 1998 The thyroid: development, structure and function. In: DeGroot LJ, ed. Endocrinology. 3rd ed. Philadelphia: W. B. Saunders Company; 281-288
4. Gentile F, Lauro RD, Salvatore G 1995 Biosynthesis and secretion of thyroid hormones. In: DeGroot LJ, ed. Endocrinology. 3rd ed. Philadelphia: W. B. Saunders Company; 571-542
5. Di Lauro R, Obici S, Acquaviva AM, Alvino CG 1982 Construction of recombinant plasmids containing rat thyroglobulin mRNA sequences. Gene 19:117-125
6. Van Heuverswyn B, Streydio C, Brocas H, Refetoff S, Dumont J, Vassert G 1984 Thyrotropin controls transcription of the thyroglobulin gene. Proc Natl Acad Sci USA 81:5941-5945
7. Gerard CM, Lefort A, Christophe D, Libert F, van Sande J, Dumont TE, Vassart G 1989 Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms. Mol Endocrinol 3:2110-2118
8. Saltiel AR, Powell-Jones CHJ, Thomas Jr CG, Nayfeh SN 1981 Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function. Endocrinology 109:1578-1589
9. Van Heuverswyn B, Streydio C, Brocas H, Refetoff S, Dumont J, Vassart G 1984 Thyrotropin controls transcription of the thyroglobulin gene. Proc Natl Acad Sci USA 81:5941-5945
10. Can Heuversuyn B, Leriche A, Van Sande J, Dumont JE, Vassart G 1985 Transcriptional control of thyroglobulin gene expression by cyclic AMP. FEBS Lett 188:192-196
11. Blaese RM, Ishii-Morita H, Mullen C, Ramsey J, Ram Z, Olddfield E, Culver K 1994 In situ delivery of suicide genes for cancer treatment. Eur J Cancer 30A:1190-1193
12. Ishii-Morita H, Agbaria R, Mullen CA, Hirano H, Koeplin DA, Ram Z, Oldfield EH, Johns DG, Blaese RM. 1997 Mechanism of 'bystander effect' killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment. Gene Ther 4:244-251
13. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LR, Albelda SM 1995 Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 13:7-16
14. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL 1995 Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 55:5283-5287
15. Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molson JM, Albelda SM, Kaiser LR 1998 Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy. Results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 9:1083-1092
16. Mullen CA, Anderson L, Woods K, Nishino M, Petropoulos D 1998 Ganciclovir chemoablation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses. Hum Gene Ther 9:2019-2030
17. Nishihara E, Nagayama Y, Mawatari F, Tanaka K, Namba H, Niwa M, Yamashita S 1997 Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo. Endocrinology 138:4577-4583
18. Castro MG 1999 Gene therapy strategies for the treatment of pituitary tumors. J Mol Endocrinol 22:9-18
19. Goebel EA, Davidson BL, Zabner J, Graham S, Kern JA 1996 Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 105:562-567
20. Uckert W, Kammertons T, Haack K, Qin Z, Gebert J, Schendel DJ, Blankenstein T 1998 Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 9:855-865
21. Klatzmann D, Cherin P, Bensimon G, Boyer O, Coutellier A, Charlotte F, Boccaccio C, Salzmann J-L, Herson S 1998 A phase I/II dose-escalation study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for metastatic melanoma. Hum Gene Ther 9:2585-2594
22. Klatzmann D, Valery CA, Bensimon G, Marro B, Boyer O, Mokhtari K, Diquet B, Salzmann JL, Philippon J 1998 A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Hum Gene Ther 9:2595-2604
23. Moolten F 1986 Tumor chemosensitivity conferred by inserted herpes kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46:5276-5281
24. Zhang R, Minemura K, DeGroot L J 1998 Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2. Endocrinology 139:601-608
25. Haddada H, Ragot T, Cordier L, Duffour MT, Perricaudet M 1993 Adenoviral interleukin-2 gene transfer into p815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum Gene Ther 4:703-711
26. Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL 1996 Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum Gene Ther 7:1995-2002
27. Huang H, Chen SH, Kosai K, Finegold MJ, Woo SLC 1996 Gene therapy for hepatocellular carcinoma: long-term remission of primary and metastatic tumors in mice by interleukin-2 gene therapy in vivo. Gene Ther 3:980-987
28. Gilligan MG, Knox P, Weedon S, Barton R, Kerr DJ, Searle P, Young LS 1998 Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells. Gene Ther 5:965-974
29. Cordier L, Duffour MT, Sabourin JC, Lee MG, Cabannes J, Ragot T, Perricaudet M, Haddada H 1995 Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL2 gene. Gene Ther 2:16-21
30. Zhang R, Baunoch D, DeGroot LJ 1998 Genetic immunotherapy for medullary thyroid carcinoma: destruction of tumors in mice by in vivo delivery of adenoviral vector transducing the murine interleukin-2 gene. Thyroid 8:1137-1146
31. Zhang R, Straus FH, DeGroot LJ 1999 Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: dissemination and cytotoxicity studies in a rat tumor model. Endocrinology 140:2152-2158
32. Huard J, Lochmller H, Acsadi C, Jani A, Massie B, Karpati G 1995 The rout of the administration is a major determinant of transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
33. de Roos WK, Fallaux FJ, Marinelli AWKS, Lazaris-Karatzas A, von Geusau BA, van der Eb MM, Cramer SJ, Terpstra OT, Hoeben RC 1997 Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. Gene Ther 4:55-62
34. Chen L, Chen D, Manome Y, Dong Y, Fine HA, Kufe DW 1995 Breast cancer selective gene expression and therapy mediated by recombinant adenovirus containing the DF3/MUC1 promoter. J Clin Invest 96:2775-2782
35. Anderson LM, Swaminathan S, Zackon I, Tajuddin A-K, Thimmapaya B, Weitzman SA 1999 Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer. Gene Ther 6:854-864
36. Kaneko S, Hallenbech P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Andeson WF, Chiang YL 1995 Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 55:5283-5287
37. Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M 1996 Gene therapy for a-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene Hepatology 23:1359-1368
38. Lee EJ, Anderson LM, Thimmapaya B, Jameson JL 1999 Targeted expression of toxic directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors. J Clin Endocrinol Metab 84:786-794
39. Ko SC, Cheon J, Kao C, Gotoh A, Shirakawa T, Sikes RA, Karsenty G, Chung LWK 1996 Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models. Cancer Res 56:4614-4619
40. Parr M, Manome Y, Tanaka T, Wen P, Kufe DW, Kaelin Jr WG, Fine HA 1997 Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat Med 10:1145-1149
41. Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Oich EM, Huijsduijnen RHV 1998 Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther 5:1213-1220
42. Morelli AE, Larregina AT, Smith-Arica J, Dewey RA, Southgate TD, Ambar B, Fontana A, Castro MG, Lowenstein PR 1999 Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand predetermined brain cell types, and abolish peripheral liver toxicity. J Gen Virol 80:571-583
43. Zhang R, Straus FH, DeGroot LJ 2001 Adenoviral mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specific and low toxicity. Thyroid 11:115-123
44. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from ratthyroids. Proc Natl Acad Sci USA 77:3455-3459
45. Valente WA, Vitti P, Kohn LD, Brandi ML, Rotella CM, Toccafondi R, Tramontano D, Aloj SM, Ambesi-Impiombato FS 1983 The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology 112:71-79
46. Graham FL, Vandereb EJ 1973 A new technique for the assay of infective human adenovirus 5 DNA. Virology 52:456-467
47. Graham FL, Smiley J, Russell WC, Nairn R 1977 Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-72
48. Zhang R, DeGroot LJ 2001 An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity againist medullary thyroid carcinoma. Endocr Relat Cancer 8:315-325
49. Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McCcelland A, Kaleko M 1993 Adenovirus-mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397-402
50. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SLC 1993 Assessment of recombinant adenovirial vector for hepatic gene therapy. Hum Gene Ther 4:403-409
51. Imler JL, Dupuit F, Chartier C, Accart N, Dieterle A, Schultz H, Puchelle E1996 Targeted cell-specific gene expression with an adenovirus vector containing the LacZ gene under the control of the CFTR promoter. Gene Ther 3:49-58
52. Ring CJA, Harris JD, Hurst HC, Lemoine NR 1996 Suicide gene expression induced in tumor cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter. Gene Ther 3:1094-1103
53. Wallace H, Ledent C, Vassart G, Bishop JO, Al-Shawi R 1991 Specific ablation of thyroid follicle cells in adult transgenic mice. Endocrinology 129:3217-3226
54. Zeiger MJ, Takiyama Y, Bishop JO, Ellison AR, Saji M, Levine MA 1996 Adenoviral infection of thyroid cells: a rationale for gene therapy for metastatic thyroid carcinomas. Surgery 120:921-925
55. Braiden V, Nagayama Y, Iitaka M, Namba H, Niwa M, Yamashita S 1998 Retro-virus mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter. Endocrinology 139:3996-3999